8-K: Cross Country Healthcare Appoints Co-Founder Kevin Clark as CEO

Cross Country Healthcare announced the departure of CEO John A. Martins and the immediate appointment of co-founder and Chairman Kevin C. Clark as his successor, effective December 14, 2025.

Summary

• John A. Martins separated from his roles as President, CEO, and Board member, effective December 14, 2025.
• Mr. Martins will receive a cash severance payment equal to two years of his $875,000 base salary, plus two times his average actual bonus from the prior three calendar years, payable over 24 months.
• He will also receive 24 months of continued benefits (if elected) and full vesting of all unvested equity awards, with performance share awards vesting at target level, contingent on a waiver and release of claims.
• Kevin C. Clark, the Company's current Chairman, former CEO, and co-founder, was appointed President and CEO, effective December 14, 2025.
• Mr. Clark will continue to serve as Chairman of the Board.
• The Board size was reduced from seven to six members following Mr. Martins' departure.
• The CEO transition follows the termination of the proposed merger with Aya Healthcare.
• The Company intends to file an amendment to the 8-K once Mr. Clark's employment agreement and compensation terms are determined.

Sentiment

Score: 4

Explanation: The sentiment is mixed to slightly negative. While the appointment of an experienced co-founder as CEO is a positive, the underlying reason for the CEO change (termination of a major merger) is a significant negative. The substantial severance package also impacts sentiment. The future outlook statements are positive, but they are forward-looking and not yet realized.

Positives

• Kevin C. Clark, a co-founder and former CEO with nearly 40 years of healthcare staffing experience, returns, having previously led the company through a period of rapid growth and strong financial results from 2019 to 2022.
• The Board expresses confidence in Mr. Clark's "transformative leadership and operational excellence" to chart the company's next phase of financial growth.
• Mr. Clark plans to usher in a new era of "innovative AI-led, tech-enabled workforce solutions," sharpen focus, reduce costs, and optimize capital allocation for sustainable, long-term profitable growth.

Negatives

• The departure of the President and CEO, John A. Martins, creates leadership uncertainty, despite the immediate appointment of a successor.
• The CEO transition is explicitly linked to the termination of the proposed merger with Aya Healthcare, indicating a significant strategic setback.
• The terms of the new CEO, Kevin C. Clark's, compensation have not yet been determined, which could be a point of future negotiation or uncertainty.
• A substantial severance package for the departing CEO, including two years of base salary ($1.75 million) and two times the average bonus, plus benefits and equity vesting, will be incurred by the company.

Risks

• Risks related to the termination of the proposed merger with Aya Healthcare, Inc.
• Risks related to the CEO transition, including the Company's ability to retain customers and retain and hire key personnel.
• Risks related to maintaining relationships with suppliers and customers during the transition.
• Worldwide economic or political changes that affect the markets the Company serves, potentially impacting demand for services and profitability.
• Effects from global pandemics, epidemics, or other public health crises.
• Changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, and customer needs.
• Disruptions in the global credit and financial markets, including diminished liquidity and credit availability.
• Changes in international trade agreements, including tariffs and trade restrictions.
• Cyber-security vulnerabilities.
• Foreign currency volatility.
• Swings in consumer confidence and spending.
• Costs of providing services.
• Retention of key employees.
• Outcomes of legal proceedings, claims, and investigations.

Future Outlook

Kevin C. Clark, the newly appointed CEO, expressed his belief in the Company's future and his intention to redefine its trajectory as an innovative tech-enabled workforce solutions leader. He plans to sharpen focus, reduce costs, optimize capital allocation, and make disciplined investments to drive sustainable, long-term profitable growth for shareholders. The Company aims to usher in a new era of AI-led, tech-enabled workforce solutions.

Management Comments

• "The Board members are thrilled to have Kevin return as Cross Countrys CEO to embark on a new chapter of growth." Larry Cash, Lead Independent Director.
• "Kevin brings nearly 40 years of experience in the healthcare staffing industry." Larry Cash, Lead Independent Director.
• "Kevin has a proven record of transformative leadership and operational excellence. He is the right leader to chart Cross Countrys next phase of financial growth." Larry Cash, Lead Independent Director.
• "Kevin is an extraordinary leader whose passion and vision will usher in a new era of innovative AI-led, tech-enabled workforce solutions at Cross Country." Larry Cash, Lead Independent Director.
• "In light of the termination of the transaction with Aya Healthcare, the Board believes that it is the right time for a CEO transition." Larry Cash, Lead Independent Director.
• "On behalf of the entire Board, we thank John for his service and contributions to the Company." Larry Cash, Lead Independent Director.
• "I believe in Cross Country and its future, and I am honored to be returning as its CEO." Kevin C. Clark, President and CEO.
• "Cross Country stands at a pivotal moment, with the opportunity to redefine its trajectory as an innovative tech-enabled workforce solutions leader built on a nearly 40-year legacy as an iconic brand in our industry." Kevin C. Clark, President and CEO.
• "We will sharpen our focus, reduce our costs to serve, and optimize our capital allocation strategy so we can make meaningful, disciplined investments that drive sustainable, longterm profitable growth for our shareholders." Kevin C. Clark, President and CEO.

Industry Context

The healthcare staffing and workforce solutions industry is dynamic, with increasing demand for tech-enabled and AI-led solutions to address complex labor challenges. The return of a co-founder and experienced leader like Kevin Clark, with a focus on innovation and cost reduction, suggests the company is positioning itself to adapt to these trends and potentially regain market share or improve efficiency, especially after the termination of a significant merger. The emphasis on "AI-led, tech-enabled workforce solutions" indicates a strategic alignment with broader technological advancements in the sector.

Management Changes

Corporate Governance

Related Party Transactions

• The Company has not entered into any transactions with Mr. Clark reportable under Item 404(a) of Regulation S-K, other than those disclosed on page 31 of the 2025 Proxy Statement, which are incorporated by reference.

Stakeholder Impact

• Shareholders: Potential for increased volatility due to CEO transition and failed merger. New CEO's strategic focus on profitable growth and optimized capital allocation aims to benefit shareholders long-term. Significant severance package for former CEO impacts shareholder value.
• Employees: CEO transition can create uncertainty but also new strategic direction. Focus on "AI-led, tech-enabled workforce solutions" might imply shifts in roles or skill requirements.
• Customers: Risks mentioned include the Company's ability to retain customers and maintain relationships during the CEO transition. New CEO's focus on "unrelenting quality, clinical excellence and deep client relationships" aims to reassure customers.
• Suppliers: Risks mentioned include the Company's ability to maintain relationships with suppliers during the CEO transition.
• Creditors: No direct impact mentioned, but strategic shifts and financial performance (including severance costs) could indirectly affect creditworthiness.

Next Steps

• The Company and Kevin C. Clark intend to enter into an employment agreement.
• The Company intends to file an amendment to this Current Report on Form 8-K if and when the terms of Mr. Clark's employment and compensation are determined.
• Kevin C. Clark plans to sharpen focus, reduce costs to serve, and optimize capital allocation strategy.
• Kevin C. Clark plans to make meaningful, disciplined investments to drive sustainable, long-term profitable growth.

Key Dates

Recommendation

The filing presents a mixed bag. The departure of the CEO, especially linked to a failed merger, is a significant negative event that could lead to short-term uncertainty and downward pressure on the stock. However, the immediate appointment of a highly experienced co-founder and former CEO, Kevin Clark, who has a proven track record of driving growth for the company, provides a strong mitigating factor. His stated focus on innovation, cost reduction, and profitable growth offers a positive long-term vision. Given the immediate uncertainty from the transition and the failed merger, but also the potential for renewed strategic direction under experienced leadership, a 'hold' recommendation is appropriate. Investors should await further details on the new CEO's compensation and initial strategic moves before making a more definitive 'buy' or 'sell' decision.

Keywords

Cross Country Healthcare, CCRN, CEO Transition, Kevin Clark, John Martins, Healthcare Staffing, Workforce Solutions, Corporate Governance, Executive Change, Board of Directors, SEC Filing, 8-K, Aya Healthcare Merger